A number of research firms have changed their ratings and price targets for Ambev (NYSE: ABEV):
- 7/15/2026 – Ambev was downgraded by Scotiabank from “sector outperform” to “sector perform”.
- 7/13/2026 – Ambev was downgraded by Wall Street Zen from “buy” to “hold”.
- 7/5/2026 – Ambev was upgraded by Wall Street Zen from “hold” to “buy”.
- 6/27/2026 – Ambev was downgraded by Wall Street Zen from “buy” to “hold”.
Ambev Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 11th. Shareholders of record on Wednesday, June 24th will be paid a dividend of $0.0092 per share. The ex-dividend date of this dividend is Wednesday, June 24th. This represents a $0.04 annualized dividend and a yield of 1.2%. Ambev’s payout ratio is presently 10.53%.
Insiders Place Their Bets
In other Ambev news, insider Paulo Andre Zagman sold 136,250 shares of the business’s stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $3.41, for a total transaction of $464,612.50. Following the sale, the insider directly owned 230,535 shares in the company, valued at approximately $786,124.35. The trade was a 37.15% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
See Also
- Five stocks we like better than Ambev
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Ambev SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev SA and related companies with MarketBeat.com's FREE daily email newsletter.
